Rhinitis/rhinorrhea (Intranasal Products)

ZETONNA (ciclesonide) 37mcg nasal aerosol by Sunovion

Zetonna Now Available for Allergic Rhinitis

Sunovion announced the nationwide availability of Zetonna (ciclesonide) Nasal Aerosol, 74mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies.

QNASL Approved for Seasonal and Perennial Allergic Rhinitis

QNASL Approved for Seasonal and Perennial Allergic Rhinitis

Teva announced that the FDA has approved QNASL (beclomethasone dipropionate) Nasal Aerosol, a non-aqueous, “dry” nasal aerosol corticosteroid for the treatment of seasonal and perennial allergic rhinitis in adults and adolescents 12 years of age and older.

Phase 3 Study of QNASL for Seasonal and Perennial Allergic Rhinitis

Teva announced findings from four Phase 3 clinical studies that examined the efficacy and safety profile as well as impact on quality of life (QoL) of QNASL (beclomethasone dipropionate [BDP]) Nasal Aerosol, a non-aqueous, “dry” nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR).